Breaking News Instant updates and real-time market news.

HRTX

Heron Therapeutics

$17.23

0.13 (0.76%)

09:26
10/03/16
10/03
09:26
10/03/16
09:26

Heron Therapeutics likely to be weak after executive departures, says Cowen

Cowen analyst Boris Peaker noted Heron Therapeutics announced the surprising resignation of three executives. The analyst said the resignations are consistent with the company's transformation to a commercial enterprise, but the fact they are a surprise will cause the stock to be weak. However, the upcoming catalysts for the company remain unchanged. Peaker reiterated his Outperform rating and $47 price target on Heron Therapeutics shares.

HRTX Heron Therapeutics
$17.23

0.13 (0.76%)

10/03/16
LEER
10/03/16
NO CHANGE
LEER
Outperform
Heron Therapeutics management departures not reason for concern, says Leerink
Leerink analyst Jason Gerberry does not view the departure of three members of Heron Therapeutics' management team as reason for concern as two of the departures were "stop gap" hires, brought on to help the company through the Sustol complete response letter process, and the CFO change is being made so the company can fill the role with more of an outward facing individual. The analyst reiterates an Outperform rating on the shares.
08/11/16
LEER
08/11/16
NO CHANGE
Target $33
LEER
Outperform
Leerink remains positive on Heron Therapeutics ahead of Sustol launch
Leerink analyst Jason Gerberry remains positive on Heron Therapeutics ahead of a Q4 Sustol launch in chemo induced nausea and vomiting. The analyst does not anticipate reimbursement access being an issue and notes that management has articulated a strategy for dealing with the lack of a permanent J-Code at launch. Gerberry reiterates an Outperform rating and $33 price target on the shares.
08/10/16
BMUR
08/10/16
NO CHANGE
Target $55
BMUR
Buy
Heron label for Sustol could cut market by 7%, says Brean Capital
Brean Capital analyst Jonathan Aschoff points out that the label for Heron Therapeutics' Sustol does not include all of highly emetogenic chemotherapy, just 93%, because the FDA deemed that there were not enough patients on platinum-based HEC regimens in the Phase 3 trial. This may cut the target market by about 7%, but oncology doctors often prescribe drugs off-label, Aschoff tells investors in a research note. He adds that there was a "strong" response rate to Sustol in these cisplatin-treated patients. The analyst views Sustol as "highly commercially attractive" and he keeps a Buy rating on Heron with a $55 price target.
08/02/16
LEER
08/02/16
NO CHANGE
Target $38
LEER
Outperform
Heron Therapeutics price target lowered to $38 from $45 at Leerink
Leerink analyst Jason Gerberry lowered his price target for Heron Therapeutics to $38 from $45 to reflect delayed timelines for its HTX-011 approval and diminished outlook for the overall branded post-op pain market. Nonetheless, the analyst says that the company's Phase 2 topline readouts for HTX-011 in two post-surgical pain studies further solidifies his 65% probability of success for the program. Leerink has an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

NLNK

NewLink Genetics

$18.59

0.51 (2.82%)

, MRK

Merck

$62.55

0.405 (0.65%)

14:32
04/25/17
04/25
14:32
04/25/17
14:32
Hot Stocks
NewLink drops after panel questions Ebola vaccine efficacy »

Shares of NewLink…

NLNK

NewLink Genetics

$18.59

0.51 (2.82%)

MRK

Merck

$62.55

0.405 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 04

    May

  • 07

    May

  • 10

    May

  • 12

    May

  • 27

    May

  • 31

    May

  • 06

    Jun

  • 09

    Jun

  • 14

    Jun

X

U.S. Steel

$31.19

-0.01 (-0.03%)

14:31
04/25/17
04/25
14:31
04/25/17
14:31
Options
US Steel sees a large spread trade ahead of earnings »

US Steel sees a large…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

14:25
04/25/17
04/25
14:25
04/25/17
14:25
Conference/Events
Leerink healthcare analysts hold an analyst/industry conference call »

Healthcare Analysts…

WRI

Weingarten Realty

$33.75

-0.64 (-1.86%)

14:23
04/25/17
04/25
14:23
04/25/17
14:23
Recommendations
Weingarten Realty analyst commentary  »

Weingarten Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

DIS

Disney

$115.29

1.59 (1.40%)

14:19
04/25/17
04/25
14:19
04/25/17
14:19
Periodicals
Disney targets Star Wars, Frozen sequels for 2019, Deadline reports »

Disney has unveiled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

14:17
04/25/17
04/25
14:17
04/25/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
04/25/17
04/25
14:16
04/25/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUBB

Hubbell

$117.83

-3.7 (-3.04%)

14:14
04/25/17
04/25
14:14
04/25/17
14:14
Hot Stocks
Hubbell acquires connected home products maker iDevices »

iDevices announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 02

    May

  • 09

    May

  • 09

    May

  • 09

    May

TWTR

Twitter

$14.80

0.085 (0.58%)

14:13
04/25/17
04/25
14:13
04/25/17
14:13
Technical Analysis
Twitter technical comments before earnings »

Ahead of earnings news,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CL

Colgate-Palmolive

$74.15

0.49 (0.67%)

14:11
04/25/17
04/25
14:11
04/25/17
14:11
Options
Colgate attracts a call writer ahead of earnings »

Colgate attracts a call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 31

    May

SQ

Square

$18.11

0.26 (1.46%)

14:06
04/25/17
04/25
14:06
04/25/17
14:06
Options
Square call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 16

    May

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

14:05
04/25/17
04/25
14:05
04/25/17
14:05
General news
NY Fed's overnight reverse repo totaled $117.0 B, with 45 counterparties »

NY Fed's overnight…

STX

Seagate

$49.42

1.16 (2.40%)

, WDC

Western Digital

$85.77

2.66 (3.20%)

14:00
04/25/17
04/25
14:00
04/25/17
14:00
Earnings
On The Fly: What to watch in data storage earnings reports »

Companies in the data…

STX

Seagate

$49.42

1.16 (2.40%)

WDC

Western Digital

$85.77

2.66 (3.20%)

MU

Micron

$26.57

-0.75 (-2.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 31

    May

  • 07

    Jun

  • 08

    Jun

14:00
04/25/17
04/25
14:00
04/25/17
14:00
General news
Stocks drifting at session highs in afternoon trading »

Stocks have been sharply…

MTBC

Medical Transcription Billing

$0.42

-0.03 (-6.67%)

13:57
04/25/17
04/25
13:57
04/25/17
13:57
Hot Stocks
Medical Transcription Billing partners with Health Compliance Network »

MTBC announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$8.89

0.18 (2.07%)

13:54
04/25/17
04/25
13:54
04/25/17
13:54
Hot Stocks
Sprint promotion adds free fifth line to unlimited offer »

Sprint announced that for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

CMA

Comerica

$70.14

0.03 (0.04%)

13:53
04/25/17
04/25
13:53
04/25/17
13:53
Hot Stocks
Comerica raises quarterly dividend 13% to 26c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

WFC

Wells Fargo

$54.57

0.92 (1.71%)

13:51
04/25/17
04/25
13:51
04/25/17
13:51
Hot Stocks
Wells Fargo chairman: Stockholders sent board 'clear message of dissatisfaction' »

Commenting on the results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    May

  • 31

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

D

Dominion

$77.54

-0.53 (-0.68%)

13:51
04/25/17
04/25
13:51
04/25/17
13:51
Options
Downside put buyers in Dominion Resources ahead of earnings »

Downside put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 10

    May

  • 21

    May

WFC

Wells Fargo

$54.59

0.935 (1.74%)

13:50
04/25/17
04/25
13:50
04/25/17
13:50
Hot Stocks
Wells Fargo confirms all directors reelected, says votes dip as low as 53% »

Wells Fargo announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    May

  • 31

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

PG

Procter & Gamble

$89.97

0.415 (0.46%)

13:48
04/25/17
04/25
13:48
04/25/17
13:48
Technical Analysis
Procter & Gamble technical comments before earnings »

Ahead of earnings news,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

XLNX

Xilinx

$60.65

2.96 (5.13%)

13:46
04/25/17
04/25
13:46
04/25/17
13:46
Options
Xilinx call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVHY

Vivendi

$20.34

1.39 (7.34%)

13:45
04/25/17
04/25
13:45
04/25/17
13:45
Periodicals
Vivendi's UMG valued at $22B by banks seeking float, Reuters says »

Bankers aiming to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTHIY

Hitachi

$53.93

0.09 (0.17%)

, KKR

KKR

$17.51

0.25 (1.45%)

13:45
04/25/17
04/25
13:45
04/25/17
13:45
Periodicals
Hitachi plans to sell chipmaking device unit to KKR, JIP, Nikkei reports »

Hitachi (HTHIY) is…

HTHIY

Hitachi

$53.93

0.09 (0.17%)

KKR

KKR

$17.51

0.25 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

CLRO

ClearOne

$10.00

0.1 (1.01%)

13:43
04/25/17
04/25
13:43
04/25/17
13:43
Hot Stocks
ClearOne says awarded patent on 'beamforming' echo cancellation »

ClearOne announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.